AlectorvsMerck & Company

ALEC and MRK stock compared: price, dividend, valuation and results, from SEC filings.

ALEC

Alector, Inc.

$2.33

Value $348M

+1.52%
ALEC's page

MRK

Merck & Company, Inc.

$133.72

Value $331B

+0.69%
MRK's page

Alector (ALEC) has a market value of $348M and Merck & Company (MRK) $331B. Over the last year, with dividends, ALEC moved +91.8% and MRK +44.8%. The P/E is 8.4 for ALEC and 134.8 for MRK. Dividend yield: ALEC none, MRK 2.54%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ALEC$348M

    MRK$331B

    MRK is 951 times ALEC

  • Revenue, 12 months

    ALEC$173M

    MRK$67.4B

    MRK is 388 times ALEC

  • Net income, 12 months

    ALEC$41M

    MRK$2.5B

    MRK is 59 times ALEC

  • Operating margin

    ALEC20.2%

    MRK–

  • ROIC

    ALEC56.5%

    MRK3.9%

    52.6 points apart

  • P/E

    ALEC8.4

    MRK134.8

    MRK is 16 times ALEC

  • Dividend yield

    ALEC0.0%

    MRK2.5%

    2.5 points apart

  • 5-year return

    ALEC-89.1%

    MRK+93.0%

    182.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ALEC-89.1%

MRK+93.0%

010020020222023202420252026
Returns by period
PeriodALECWith dividendsMRKWith dividends
1 year since November 19, 2025+91.8%Price +91.8%+44.8%Price +40.7%
3 years since November 20, 2023-52.4%-21.9% a yearPrice -52.4%+42.7%+12.6% a yearPrice +30.2%
5 years since November 19, 2021-89.1%-35.8% a yearPrice -89.1%+93.0%+14.1% a yearPrice +65.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ALECAlectorMRKMerck & Company

Valuation

ALECMRK
Valuation
Price$2.33$133.72
Market value$348M$331B
Enterprise value (EV)$209M$375B
P/E8.4134.8
P/E, 5-year median–14.8
P/B3.07.4
EV/EBIT6.078.7
Free cash flow yield–4.5%

Results and growth

ALECMRK
Results and growth
Revenue, 12 months$173M$67.4B
Net income, 12 months$41M$2.5B
Free cash flow, 12 months-$150M$14.7B
Earnings per share, 12 months$0.28$0.98
Revenue growth, year on year-79.1%1.3%
Revenue growth a year, past-0.1%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

ALECMRK
Margins and returns on capital
Gross margin–71.8%
Operating margin20.2%–
Net margin23.9%3.6%
ROIC56.5%3.9%
ROE100.8%5.2%

Balance sheet

ALECMRK
Balance sheet
Cash$139M$9.7B
Total debt$21M$53.8B
Net debt / EBITDA-3.45.7
Interest cover–2.4×

Dividends and buybacks

ALECMRK
Dividends and buybacks
Dividend yield–2.5%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.5%
Shareholder yield–4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ALEC or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Alector or Merck & Company?

By market value, Merck & Company ($331B) is about 951.0 times Alector ($348M), at today's prices.

How did ALEC and MRK stock do over the last 5 years?

Since November 19, 2021, ALEC's price moved -89.1% and MRK's +65.7%. With dividends: ALEC -89.1% (-35.8% a year), MRK +93.0% (+14.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, ALEC or MRK?

The dividend yield at today's price is none for Alector and 2.54% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of ALEC and MRK?

At today's price, the P/E is 8.4 for ALEC and 134.8 for MRK. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Alector or Merck & Company?

Over the last twelve months, the net margin was 23.9% for Alector and 3.6% for Merck & Company, and the operating margin 20.2% and –. Revenue was $173M and $67.4B.

Which is the better investment, Alector or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.